Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | ORBIMED CAPITAL LLC | 0 0.000% | -2,583,821 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,246,503 (Position Closed) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners III, L.P. | 2,208,812 6.400% | 136,803 (+6.60%) | Filing History |
| 2023-02-14 1:13 pm Sale | 2022-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Boxer Capital LLC | 698,861 2.000% | -1,540,000 (-68.78%) | Filing History |
| 2023-02-14 11:03 am Sale | 2022-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Ikarian Capital, LLC | 460,416 1.300% | -1,289,627 (-73.69%) | Filing History |
| 2023-02-13 09:06 am Purchase | 2022-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | BlackRock, Inc. BLK | 1,727,829 5.000% | 1,727,829 (New Position) | Filing |
| 2023-01-19 09:19 am Purchase | 2022-12-30 | 13G | MILESTONE PHARMACEUTICALS INC MIST | GOLDMAN SACHS GROUP INC GS | 2,750,385 8.000% | 2,750,385 (New Position) | Filing History |
| 2023-01-18 4:40 pm Purchase | 2022-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Integrated Core Strategies (US) LLC | 2,195,029 6.400% | 290,732 (+15.27%) | Filing History |
| 2022-10-31 4:40 pm Purchase | 2022-10-25 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Integrated Core Strategies (US) LLC | 1,904,297 6.300% | 1,904,297 (New Position) | Filing History |
| 2022-10-24 12:46 pm Sale | 2022-10-20 | 13D | MILESTONE PHARMACEUTICALS INC MIST | Novo Holdings A/S | 1,378,538 4.600% | -719,175 (-34.28%) | Filing History |
| 2022-09-26 4:04 pm Purchase | 2022-09-20 | 13D | MILESTONE PHARMACEUTICALS INC MIST | Novo Holdings A/S | 2,097,713 7.000% | 16,828 (+0.81%) | Filing History |
| 2022-09-19 9:14 pm Purchase | 2022-09-09 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners III, L.P. | 2,072,009 6.900% | 2,072,009 (New Position) | Filing History |
| 2022-02-14 4:54 pm Sale | 2021-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Boxer Capital LLC | 2,238,861 7.500% | -238,333 (-9.62%) | Filing History |
| 2022-02-14 4:36 pm Sale | 2021-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Ikarian Capital, LLC | 1,750,043 5.900% | -86,502 (-4.71%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | RA CAPITAL MANAGEMENT L.P. | 2,246,503 7.500% | -81,211 (-3.49%) | Filing History |
| 2022-02-14 08:03 am Sale | 2021-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | RTW Investments, LP | 4,315,102 14.400% | -99 (-0.00%) | Filing History |
| 2022-02-11 4:32 pm Purchase | 2021-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | ORBIMED CAPITAL LLC | 2,583,821 8.700% | 90,712 (+3.64%) | Filing History |